1039P First-in-human phase I study of givastomig, a novel Claudin 18.2/4-1BB bispecific antibody in advanced solid tumors. - Ku, G.; Shen, L.; Klempner, S.J.; Pan, H.; Kratz, J.; Liang, X.; Deng, Y.; Kim, S.; Wang, Z.; Feller, L.; Powderly, J.; Dayyani, F.; et al. (Annals of Oncology, 2023)